Dongpeng Highlights Sustainable Procurement at UN Global Compact Leaders Summit

Dongpeng Highlights Sustainable Procurement at UN Global Compact Leaders Summit

Supplier capability building and circular materials connect sustainability requirements with opportunities for collaboration FOSHAN, China, Oct. 8, 2026 /PRNewswire/ -- Guangdong Dongpeng Holdings Co., Ltd. (SZSE: 003012), a Chinese building...

LEIFRAS Co., Ltd. Reports First Half of Fiscal Year 2026 Financial Results

LEIFRAS Co., Ltd. Reports First Half of Fiscal Year 2026 Financial Results

Record-High First-Half Revenue and Operating Income, Up 8.9% and 35.9% Year Over Year, Respectively [1] TOKYO, Oct. 8, 2026 /PRNewswire/ -- LEIFRAS Co., Ltd. (Nasdaq: LFS) (the "Company" or "Leifras"), a sports and social business company dedicated...

Leifras Launches Official Note Channel "Story of LEIFRAS"

Leifras Launches Official Note Channel "Story of LEIFRAS"

A New Corporate Communications Platform Launched in Leifras' 25th Anniversary Year to Share the People, Perspectives and Stories Behind Its Business - First "ITO'S MESSAGE" to Be Published on October 9, Marking the First Anniversary of Leifras'...

TOYO Celebrates Completed 2 GW Module Expansion at Texas Facility with Ribbon-Cutting Ceremony

TOYO Celebrates Completed 2 GW Module Expansion at Texas Facility with Ribbon-Cutting Ceremony

U.S. Department of Commerce, Consulate General of Japan in Houston, and industry partners join TOYO in Humble, Texas; Company shares plans for HJT cell line TOKYO, Oct. 7, 2026 /PRNewswire/ -- On October 6, TOYO Co., Ltd (Nasdaq: TOYO) ("TOYO" or...

CARES 4.0 Agent Debuts; Hospital Presidents from HK and Shenzhen Convene on AI Adoption; Bringing Together Medicine, Research, Industry, and Investment

CARES 4.0 Agent Debuts; Hospital Presidents from HK and Shenzhen Convene on AI Adoption; Bringing Together Medicine, Research, Industry, and Investment

—— The 4th CREATE Symposium Charts a Commercialization Path for the Future of Smart Healthcare HONG KONG, Oct. 6, 2026 /PRNewswire/ -- This September, experts from the medical and engineering communities gathered in Hong Kong to exchange industry...

Applied Intuition Partners with Honda to Accelerate Next-Generation Software-Defined Vehicles

Applied Intuition Partners with Honda to Accelerate Next-Generation Software-Defined Vehicles

Collaboration brings Silicon Valley software speed and Japanese engineering excellence together to advance Honda's full-vehicle SDV platform SUNNYVALE, Calif. and TOKYO, Oct. 6, 2026 /PRNewswire/ -- Applied Intuition, Inc., a leader in physical AI...

MILANO FASHION WEEK® - SPRING/SUMMER 2027 SHENZHEN FUTIAN FASHION EVENT

MILANO FASHION WEEK® - SPRING/SUMMER 2027 SHENZHEN FUTIAN FASHION EVENT

Three brands in the spotlight: Laurel, IDPAN and YINER MILAN, Oct. 6, 2026 /PRNewswire/ -- Futian's fashion industry returned to Milano Fashion Week® with Camera Nazionale della Moda Italiana. Supported by the People's Government of Futian District,...

Energenesis Biomedical and Yoo Young Pharm Sign MOU for ENERGI-F703DFU Development and Commercialization in Korea

Energenesis Biomedical and Yoo Young Pharm Sign MOU for ENERGI-F703DFU Development and Commercialization in Korea

TAIPEI, Oct. 5, 2026 /PRNewswire/ -- Energenesis Biomedical Co., Ltd. (TWSE: 6657) today announced that it has signed a Memorandum of Understanding ("MOU") with Yoo Young Pharm. Co., Ltd. ("YYP"), a South Korea-based pharmaceutical company, to...

AnnJi Pharmaceutical Advances AJ201 into Pivotal Phase 3 ROMA-KD Trial for Spinal and Bulbar Muscular Atrophy (SBMA)

AnnJi Pharmaceutical Advances AJ201 into Pivotal Phase 3 ROMA-KD Trial for Spinal and Bulbar Muscular Atrophy (SBMA)

The only known investigational therapy for SBMA in Phase 3 development worldwide AJ201 (rosolutamide) is an investigational oral small molecule designed to address multiple disease mechanisms of spinal and bulbar muscular atrophy (SBMA, or Kennedy's...

Celaid Therapeutics Completes Second Close of Series B Financing Round

Celaid Therapeutics Completes Second Close of Series B Financing Round

Shionogi & Co., Ltd. and Teikoku Ventures, Inc. Join the Round to Accelerate U.S. Clinical Trial Preparations for CLD-001 TOKYO, Oct. 5, 2026 /PRNewswire/ -- Celaid Therapeutics Inc. (Head Office: Bunkyo-ku, Tokyo, Japan; President and CEO:...

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ...
  • 157
  • menu
    menu